GlassScriptPhysician profile
Peter S Dovgan
NPI 1396857611
$76,445.56
in general payments reported to CMS, 2019-2025
33 companies · $5,772 in 2025
The $5,772 reported for 2025 was more than what 86% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,713 · 2020: $453 · 2021: $3,207 · 2022: $6,403 · 2023: $48K · 2024: $9,186 · 2025: $5,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $60K · Food and Beverage: $2,854 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $59,650.00 |
| Food and Beverage | $2,853.74 |
| Education | $165.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $68,564.04 | 2020-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $2,486.88 | 2019-2021 | |
| Silk Road Medical, INC. | $1,073.57 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Cook Medical LLC | $768.35 | 2019-2025 | Zilver Ptx, Advance, Rosen |
| Janssen Pharmaceuticals, INC | $706.29 | 2019-2024 | Xarelto |
| Cvrx, INC. | $363.38 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $349.90 | 2024-2025 | Esprit, Absolute Pro |
| Endologix LLC | $272.69 | 2025 | Endocross Device, Torus Stent Graft System |
| Surmodics, INC. | $239.08 | 2024 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| W. L. Gore & Associates, INC. | $195.63 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Balloon Sheath With Dilator, Gore Acuseal Cardiovascular Patch Vascular |
| Medtronic, INC. | $181.62 | 2022-2025 | Closurefast, Endurant Iis |
| Shockwave Medical, INC | $170.11 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Heron Therapeutics, INC. | $128.06 | 2023 | Zynrelef |
| Boston Scientific Corporation | $114.25 | 2019-2025 | Enroute Transcarotid Neuroprotection System, Varithena Administration Pack |
| Tactile Systems Technology INC | $99.83 | 2019-2025 | Nimbl, Flexitouch Plus |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $95.00 | 2023 | |
| Cardio Flow, INC. | $91.07 | 2023-2024 | |
| Bard Peripheral Vascular, INC. | $87.91 | 2021-2023 | Venclose Maven Catheter |
| Penumbra, INC. | $59.70 | 2022-2023 | Indigo System |
| Smith+Nephew, INC. | $46.99 | 2020-2024 | Pico 14, Renasys Touch |
| Qapel Medical INC | $43.09 | 2023 | |
| Kci USA, INC. | $40.87 | 2022-2023 | Prevena |
| Teleflex LLC | $35.71 | 2019-2020 | |
| Lemaitre Vascular, INC. | $35.07 | 2022-2024 | Artegraft Vascular Graft |
| Cardiva Medical, INC. | $33.71 | 2019-2023 | Cardiva Vascade 6/7f Vcs |
| Stryker Corporation | $30.67 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inari Medical, INC. | $27.30 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bolton Medical INC | $26.97 | 2025 | Treo Abdominal Stent-Graft System |
| Baxter Healthcare | $25.09 | 2019 | |
| Avinger INC. | $16.99 | 2019 | |
| Cashflow Solutions, LLC | $14.18 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Cardinal Health 200 LLC | $12.84 | 2019 | |
| Reflow Medical INC | $8.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$172,544.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Dovgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.